ReviewUrologie (Heidelberg, Germany)2023

[Androgen deprivation therapy plus chemotherapy ± androgen receptor-targeting agents for metastatic hormone-sensitive prostate cancer].

Mike Wenzel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.